Insulet
PODD
#1015
Rank
C$27.31 B
Marketcap
$388.93
Share price
-0.49%
Change (1 day)
73.78%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.32

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.45. In 2022 the company made an earnings per share (EPS) of $0.09983 a decrease over its 2021 EPS that were of $0.33.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.322225.34%
2022$0.09983-69.57%
2021$0.33109.09%
2020$0.16-38.89%
2019$0.26200%
2018$0.08557-113.04%
2017-$0.66-9.8%
2016-$0.73-60.77%
2015-$1.8539.78%
2014-$1.3312.05%
2013-$1.18-23.15%
2012-$1.5410.2%
2011-$1.40-36.36%
2010-$2.20-36.63%
2009-$3.47-29.36%
2008-$4.91-86.74%
2007-$37.00-64.04%
2006-$102.90122.23%
2005-$46.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.88-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.61-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.40-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.09 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.24 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.88 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.74 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA